| Term | Count | % | | TREATMENT FAILURE | 5918 | 6.94% |
| DRUG INEFFECTIVE | 3246 | 3.81% |
| EYE IRRITATION | 2470 | 2.90% |
| FATIGUE | 2299 | 2.70% |
| INTRAOCULAR PRESSURE INCREASED | 1859 | 2.18% |
| HEADACHE | 1820 | 2.13% |
| EYE PAIN | 1776 | 2.08% |
| DEATH | 1650 | 1.93% |
| DYSPNOEA | 1650 | 1.93% |
| VISION BLURRED | 1628 | 1.91% |
| DIZZINESS | 1618 | 1.90% |
| DIARRHOEA | 1617 | 1.90% |
| OFF LABEL USE | 1592 | 1.87% |
| NAUSEA | 1563 | 1.83% |
| OCULAR HYPERAEMIA | 1471 | 1.72% |
| FALL | 1419 | 1.66% |
| CATARACT | 1374 | 1.61% |
| GLAUCOMA | 1367 | 1.60% |
| PAIN | 1289 | 1.51% |
| ASTHENIA | 1272 | 1.49% |
| HYPERSENSITIVITY | 1169 | 1.37% |
| RASH | 1036 | 1.21% |
| VISUAL IMPAIRMENT | 1032 | 1.21% |
| MALAISE | 1010 | 1.18% |
| PNEUMONIA | 991 | 1.16% |
| WEIGHT DECREASED | 963 | 1.13% |
| PRURITUS | 959 | 1.12% |
| CONDITION AGGRAVATED | 946 | 1.11% |
| ARTHRALGIA | 926 | 1.09% |
| PAIN IN EXTREMITY | 924 | 1.08% |
| COUGH | 908 | 1.06% |
| VOMITING | 869 | 1.02% |
| HYPERTENSION | 844 | 0.99% |
| EYE PRURITUS | 808 | 0.95% |
| DRUG HYPERSENSITIVITY | 768 | 0.90% |
| PRODUCT DOSE OMISSION ISSUE | 743 | 0.87% |
| CONSTIPATION | 741 | 0.87% |
| VISUAL ACUITY REDUCED | 732 | 0.86% |
| DRY EYE | 725 | 0.85% |
| PYREXIA | 695 | 0.81% |
| INSOMNIA | 693 | 0.81% |
| CONFUSIONAL STATE | 690 | 0.81% |
| EYE DISORDER | 662 | 0.78% |
| DEPRESSION | 653 | 0.77% |
| DECREASED APPETITE | 647 | 0.76% |
| BACK PAIN | 626 | 0.73% |
| CEREBROVASCULAR ACCIDENT | 608 | 0.71% |
| PRODUCT QUALITY ISSUE | 608 | 0.71% |
| URINARY TRACT INFECTION | 599 | 0.70% |
| ACUTE KIDNEY INJURY | 597 | 0.70% |
| SOMNOLENCE | 595 | 0.70% |
| GAIT DISTURBANCE | 578 | 0.68% |
| ANAEMIA | 558 | 0.65% |
| INCORRECT DOSE ADMINISTERED | 554 | 0.65% |
| BLOOD PRESSURE INCREASED | 542 | 0.64% |
| ANXIETY | 541 | 0.63% |
| HYPOTENSION | 533 | 0.62% |
| FEELING ABNORMAL | 531 | 0.62% |
| ABDOMINAL DISCOMFORT | 527 | 0.62% |
| CHEST PAIN | 527 | 0.62% |
| PALPITATIONS | 524 | 0.61% |
| LACRIMATION INCREASED | 521 | 0.61% |
| ERYTHEMA | 507 | 0.59% |
| COVID-19 | 502 | 0.59% |
| BLINDNESS | 479 | 0.56% |
| PERIPHERAL SWELLING | 477 | 0.56% |
| MYALGIA | 475 | 0.56% |
| PRODUCT USE ISSUE | 471 | 0.55% |
| PRODUCT USE IN UNAPPROVED INDICATION | 466 | 0.55% |
| ATRIAL FIBRILLATION | 464 | 0.54% |
| ARTHRITIS | 461 | 0.54% |
| MUSCLE SPASMS | 455 | 0.53% |
| NASOPHARYNGITIS | 454 | 0.53% |
| DRUG INTOLERANCE | 452 | 0.53% |
| TREMOR | 439 | 0.51% |
| HAEMOGLOBIN DECREASED | 438 | 0.51% |
| RENAL FAILURE | 438 | 0.51% |
| OEDEMA PERIPHERAL | 427 | 0.50% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 422 | 0.49% |
| ABDOMINAL PAIN UPPER | 421 | 0.49% |
| ABDOMINAL PAIN | 405 | 0.47% |
| ALOPECIA | 404 | 0.47% |
| DEHYDRATION | 400 | 0.47% |
| WEIGHT INCREASED | 400 | 0.47% |
| BRONCHITIS | 393 | 0.46% |
| EYE SWELLING | 392 | 0.46% |
| MUSCULAR WEAKNESS | 388 | 0.45% |
| MEMORY IMPAIRMENT | 372 | 0.44% |
| SYNCOPE | 372 | 0.44% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 370 | 0.43% |
| FOREIGN BODY SENSATION IN EYES | 366 | 0.43% |
| DYSGEUSIA | 365 | 0.43% |
| MYOCARDIAL INFARCTION | 364 | 0.43% |
| BALANCE DISORDER | 358 | 0.42% |
| BLOOD GLUCOSE INCREASED | 356 | 0.42% |
| VERTIGO | 355 | 0.42% |
| HYPOAESTHESIA | 350 | 0.41% |
| ASTHMA | 344 | 0.40% |
| PARAESTHESIA | 344 | 0.40% |
| CARDIAC FAILURE CONGESTIVE | 340 | 0.40% |
| Total | 85287 | |